about
Amantadine ameliorates dopamine-releasing deficits and behavioral deficits in rats after fluid percussion injuryA randomized, crossover study to evaluate the pharmacokinetics of amantadine and oseltamivir administered alone and in combinationPersistent cognitive dysfunction after traumatic brain injury: A dopamine hypothesisCocaine-induced neuroadaptations in glutamate transmission: potential therapeutic targets for craving and addictionPreliminary study of intravenous amantadine treatment for ataxia management in patients with probable multiple system atrophy with predominant cerebellar ataxiaChronic tobacco smoking and gender as variables affecting amantadine disposition in healthy subjectsInhibition of endosomal/lysosomal degradation increases the infectivity of human immunodeficiency virusCardiotoxicity after massive amantadine overdose.Case files of the program in medical toxicology at brown university: amantadine withdrawal and the neuroleptic malignant syndrome.Amantadine treatment following traumatic brain injury in children.The role of dopamine in symptoms and treatment of apathy in Alzheimer's disease.Adverse reactions to amantadine prophylaxis of influenza in a retirement home.Treatment of the later stages of Parkinson's disease - pharmacological approaches now and in the future.Possible involvement of cationic-drug sensitive transport systems in the blood-to-brain influx and brain-to-blood efflux of amantadine across the blood-brain barrier.Control of influenza outbreaks in the nursing home: guidelines for diagnosis and management.A Critical Role for Immune System Response in Mediating Anti-influenza Drug Synergies Assessed by Mechanistic ModelingEffects of the dopaminergic agent and NMDA receptor antagonist amantadine on cognitive function, cerebral glucose metabolism and D2 receptor availability in chronic traumatic brain injury: a study using positron emission tomography (PET).Occurrence of adverse effects and high amantadine concentrations with influenza prophylaxis in the nursing home.Comparison of amantadine and desipramine combined with psychotherapy for treatment of cocaine dependence.Amantadine to enhance readiness for rehabilitation following severe traumatic brain injury.
P2860
Q27331447-18483201-63C8-41C8-8ED3-4FF625A2FC49Q28471710-AB6AEA9F-7585-4B87-8934-E12E927CCEB0Q33589580-6A34E088-F8F8-43D3-93F4-6975794C27A3Q33626978-1A0FADD6-D943-4C9B-94C4-6A8B412FE82DQ33636298-E06B03AA-7A7D-4A69-B4C8-30BACD235ECFQ34346962-EE5FF437-C009-4893-9A6C-59B7239ADDC7Q34354703-9A810553-5CA7-4EE6-BA22-FE195F090346Q36548415-3866AB61-8D3D-40F9-948B-366871F9A9AAQ36549208-C5357228-69A9-45B1-96E2-BF4A264C8AF7Q36923005-9D47D853-66F2-40FB-9F8B-33D582034C02Q37766266-AD9A8AF2-8E9C-4A17-9A09-A51C0DD968FFQ37771068-38C955CE-C353-4DC4-AFEC-379E51A2E274Q38478999-54A37B2D-ADF7-4813-9F1B-60B08340FBF4Q38939122-E366BB8D-858B-48DE-82C4-C7F236B5E18AQ40560519-A9E1F00B-6460-4002-A7A0-A00600D59205Q41745036-519B8EAD-07C1-4EED-A279-CA6079505414Q42666322-90841EAD-410A-496C-834B-EFF4BDC7D2B7Q43830531-193DEDF1-54CD-4A66-81CB-27C4BEC4A9C8Q43860906-4CB8D05F-1CF2-41DC-96D2-802309427181Q46802583-8E8D7C64-F63C-4A31-9044-5157D530F81A
P2860
description
1988 nî lūn-bûn
@nan
1988 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1988 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
name
Clinical pharmacokinetics of amantadine hydrochloride.
@ast
Clinical pharmacokinetics of amantadine hydrochloride.
@en
Clinical pharmacokinetics of amantadine hydrochloride.
@nl
type
label
Clinical pharmacokinetics of amantadine hydrochloride.
@ast
Clinical pharmacokinetics of amantadine hydrochloride.
@en
Clinical pharmacokinetics of amantadine hydrochloride.
@nl
prefLabel
Clinical pharmacokinetics of amantadine hydrochloride.
@ast
Clinical pharmacokinetics of amantadine hydrochloride.
@en
Clinical pharmacokinetics of amantadine hydrochloride.
@nl
P1476
Clinical pharmacokinetics of amantadine hydrochloride.
@en
P2093
P356
10.2165/00003088-198814010-00003
P577
1988-01-01T00:00:00Z
P6179
1030033279